Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

G Protein-coupled Receptors01:15

G Protein-coupled Receptors

16.4K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
16.4K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

10.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.0K
Drug Discovery: Overview01:26

Drug Discovery: Overview

10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

15.2K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
15.2K
Protein-Drug Binding: Mechanism and Kinetics01:16

Protein-Drug Binding: Mechanism and Kinetics

1.6K
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
1.6K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Targeting TMPRSS2 for Prostate Cancer Therapy: A Multi-Step Computational Approach for Identifying Novel Inhibitors.

Current drug discovery technologies·2026
Same author

Mutation Analysis of SARS-CoV-2 Variants Isolated from Symptomatic Cases from Andhra Pradesh, India.

Viruses·2023
Same author

An <i>in silico</i> study on pulmonary fibrosis inhibitors from <i>Tinospora cordifolia</i> and <i>Curcuma longa</i> targeting TGF-β RI.

Journal of biomolecular structure & dynamics·2022
Same author

In silico trials to design potent inhibitors against matrilysin (MMP-7).

Journal of biomolecular structure & dynamics·2021
Same author

Design of a multi-epitope-based vaccine targeting M-protein of SARS-CoV2: an immunoinformatics approach.

Journal of biomolecular structure & dynamics·2020
Same author

Screening of <i>Ipomoea tuba</i> Leaf Extract for Identification of Bioactive Compounds and Evaluation of Its <i>in vitro</i> Antiproliferative Activity Against MCF-7 and HeLa Cells.

Food technology and biotechnology·2020

相关实验视频

Updated: Jan 10, 2026

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
03:08

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Published on: October 3, 2025

884

解码痛风病变:通过计算模型发现标和设计药物.

Hemantha Mani Kumar Chakravarthi Chanda1, Sudheer Kumar Katari1, Tejaswini Tiyyagura1

  • 1Department of Biotechnology, Vignan's Foundation for Science, Technology and Research(Deemed to be University), Vadlamudi, Guntur, 522213 India.

In silico pharmacology
|November 24, 2025
PubMed
概括

这项研究通过分析蛋白质相互作用和选天然化合物来确定痛风的新型治疗点. 来自Woodfordia fruticosa,Arctium lappa和Oroxylum indicum的植物化学物质显示出调节尿酸运输的潜力.

关键词:
停靠对接 停靠对接动力学 动力学 动力学痛风性关节炎是一种关节炎.网络分析 网络分析乌拉特1是URAC1的产品之一.

更多相关视频

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

2.7K
Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
05:50

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on: September 26, 2025

1.4K

相关实验视频

Last Updated: Jan 10, 2026

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
03:08

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Published on: October 3, 2025

884
Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

2.7K
Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
05:50

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on: September 26, 2025

1.4K

科学领域:

  • 生物信息学和计算生物学
  • 药理学和药物发现
  • 遗传学和分子生物学

背景情况:

  • 痛风是一种代谢障碍,其特征是高尿血和尿酸结晶沉积.
  • 鉴定有效的治疗点和新型痛风候选药物仍然是一个重大挑战.

研究的目的:

  • 用综合生物信息学方法预测痛风的潜在治疗点.
  • 通过分子对接和仿真来识别具有潜在的酸盐降低活性的天然化合物.

主要方法:

  • 使用STRING和Cytoscape.net对痛风相关蛋白质的基于网络的分析.
  • 基于蛋白质-蛋白质相互作用网络的重点目标SLC22A12 (URAT1) 和SLC22A9 (OAT7) 的优先级.
  • 使用IMPPAT和FDA数据库对URAT1进行植物化学品的分子对接和动态模拟.

主要成果:

  • 确定SLC22A12 (URAT1) 和SLC22A9 (OAT7) 是痛风治疗的关键标.
  • 异构素A,Arctignan D和Scutellarein 7-rutinoside与URAT1.1表现出强烈的结合亲和力和稳定性.
  • 这些天然化合物与现有的痛风药物相比,表现出优越的结合特征.

结论:

  • 这项研究提出了一个强大的计算框架,用于发现新的痛风治疗方法.
  • 来自Woodfordia fruticosa,Arctium lappa和Oroxylum indicum的植物化学物质是尿酸运输的潜在调节剂.
  • 建议对这些有前途的天然化合物作为痛风治疗方法进行进一步的体外和体内验证.